Abciximab in Wake-up Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00167765
Recruitment Status : Terminated (Higher hemorrhage rates of Abciximab in ABESST II trial)
First Posted : September 14, 2005
Last Update Posted : May 3, 2007
Eli Lilly and Company
Information provided by:
University of Zurich

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2005